Big price reduction! The latest price of genuine venetoclax/venetoclax in 2024

Venetoclax is an oral BCL2 inhibitor approved for the treatment of chronic lymphocytic leukemia or small lymphocytic leukemia in adults. Veneclat is also used in combination with other drugs to treat acute myeloid leukemia in adults who are 75 years of age or older or who have other medical conditions that prevent them from using standard chemotherapy. Studies have shown that patients with acute myeloid leukemia who achieve complete remission after induction therapy are considered candidates for receiving venetoclax monotherapy as maintenance therapy, especially older patients.

The active ingredient in venetoclaxvenetoclax attaches to a protein called Bcl-2. This protein, found in large amounts in leukemia cancer cells, helps the cells survive longer in the body and makes them resistant to cancer drugs. Venetoclax slows the progression of the disease by binding to Bcl-2 and blocking its action, causing cancer cells to die.

The original drug of Venacla has been launched in China and has been included in the Class B medical insurance. The common specifications are 10mg*14 tablets, 50mg*7 tablets, and 100mg*14 tablets. The price of each box may be 1,000-4,000 yuan, and there are differences in different specifications of drugs. The Turkish version of the original drug currently sold overseas, with a specification of 100mg*112 tablets, costs more than 10,000 yuan per box (the price may fluctuate due to exchange rates). Generic drugs of venekra are also sold overseas. Their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 100mg*120 tablets produced by a Bangladesh pharmaceutical factory is more than 4,000 yuan per box (the price may fluctuate due to the exchange rate), which is cheaper than the original drugs.